Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Lung Cancer in Non-smokers in Czech Republic: Data from LUCAS Lung Cancer Clinical Registry

O. Venclicek, J. Skrickova, K. Brat, O. Fischer, L. Havel, M. Hrnciarik, M. Marel, P. Opalka, G. Krakorova, D. Rozsivalova, J. Kultan, A. Mullerova, L. Zarnayova, P. Smickova, M. Vasakova, Z. Gyorfy, M. Jirousek, D. Krejci, J. Krejci, P. Zuna, M....

. 2021 ; 41 (11) : 5549-5556. [pub] -

Language English Country Greece

Document type Comparative Study, Journal Article, Multicenter Study

Persistent link   https://www.medvik.cz/link/bmc22003268

BACKGROUND/AIM: LUCAS is a clinical lung cancer registry (ClinicalTrials.gov identifier is NCT04228237), prospectively collecting data from newly diagnosed lung cancer patients in seven pneumooncology centers in the Czech Republic, since June 1, 2018. The aim of the study was to assess the stage of the disease at the time of diagnosis, percentage of morphological types, survival, percentage of driving mutations, eligibility for radical surgery, and percentage of patients who undergo radical surgery, in the non-smoking population in comparison with smokers and former smokers. PATIENTS AND METHODS: The total number of patients in the registry at the time of the analysis was 2,743. Only 2,439 patients with complete records (smoking status, stage, and type of tumor) were included in this study. RESULTS: The analysis indicated that non-smokers are diagnosed at a later stage of the disease but they have a better survival rate than smokers. Fewer smokers with stage III disease who are eligible for radical surgery will undergo surgery compared to non-smokers with the same clinical stage. Driving mutations are more common in non-smokers, even after adjustment for the more frequent occurrence of adenocarcinoma in the group of non-smokers. CONCLUSION: The data from LUCAS registry are consistent with already known facts, suggesting that the LUCAS registry is a useful clinical tool.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22003268
003      
CZ-PrNML
005      
20220127150515.0
007      
ta
008      
220113s2021 gr f 000 0|eng||
009      
AR
024    7_
$a 10.21873/anticanres.15368 $2 doi
035    __
$a (PubMed)34732425
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Venclicek, Ondrej $u Department of Respiratory Diseases, University Hospital Brno, Brno, Czech Republic; venclicek.ondrej@fnbrno.cz $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
245    10
$a Lung Cancer in Non-smokers in Czech Republic: Data from LUCAS Lung Cancer Clinical Registry / $c O. Venclicek, J. Skrickova, K. Brat, O. Fischer, L. Havel, M. Hrnciarik, M. Marel, P. Opalka, G. Krakorova, D. Rozsivalova, J. Kultan, A. Mullerova, L. Zarnayova, P. Smickova, M. Vasakova, Z. Gyorfy, M. Jirousek, D. Krejci, J. Krejci, P. Zuna, M. Svaton, K. Hrda, J. Duba, J. Alahakoon, M. Svoboda, J. Silar
520    9_
$a BACKGROUND/AIM: LUCAS is a clinical lung cancer registry (ClinicalTrials.gov identifier is NCT04228237), prospectively collecting data from newly diagnosed lung cancer patients in seven pneumooncology centers in the Czech Republic, since June 1, 2018. The aim of the study was to assess the stage of the disease at the time of diagnosis, percentage of morphological types, survival, percentage of driving mutations, eligibility for radical surgery, and percentage of patients who undergo radical surgery, in the non-smoking population in comparison with smokers and former smokers. PATIENTS AND METHODS: The total number of patients in the registry at the time of the analysis was 2,743. Only 2,439 patients with complete records (smoking status, stage, and type of tumor) were included in this study. RESULTS: The analysis indicated that non-smokers are diagnosed at a later stage of the disease but they have a better survival rate than smokers. Fewer smokers with stage III disease who are eligible for radical surgery will undergo surgery compared to non-smokers with the same clinical stage. Driving mutations are more common in non-smokers, even after adjustment for the more frequent occurrence of adenocarcinoma in the group of non-smokers. CONCLUSION: The data from LUCAS registry are consistent with already known facts, suggesting that the LUCAS registry is a useful clinical tool.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a nádorové biomarkery $x genetika $7 D014408
650    _2
$a nemalobuněčný karcinom plic $x diagnóza $x epidemiologie $x mortalita $x chirurgie $7 D002289
650    _2
$a bývalí kuřáci $7 D000078822
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a nádory plic $x diagnóza $x epidemiologie $x mortalita $x chirurgie $7 D008175
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mutace $7 D009154
650    _2
$a staging nádorů $7 D009367
650    12
$a nekuřáci $7 D000078405
650    _2
$a pneumektomie $7 D011013
650    _2
$a prospektivní studie $7 D011446
650    _2
$a registrace $7 D012042
650    _2
$a malobuněčný karcinom plic $x diagnóza $x epidemiologie $x mortalita $x terapie $7 D055752
650    _2
$a kuřáci $7 D000074285
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Skrickova, Jana $u Department of Respiratory Diseases, University Hospital Brno, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Brat, Kristian $u Department of Respiratory Diseases, University Hospital Brno, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic
700    1_
$a Fischer, Ondrej $u Department of Respiratory Medicine, University Hospital Olomouc, Olomouc, Czech Republic $u Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
700    1_
$a Havel, Libor $u Department of Respiratory Medicine, Thomayer Hospital, Prague, Czech Republic $u 1 Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Hrnciarik, Michal $u Pulmonary Department, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic $u Charles University, Faculty of Medicine, Hradec Kralove, Czech Republic
700    1_
$a Marel, Miloslav $u Department of Pulmonology, University Hospital Motol, Prague, Czech Republic $u 2 Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Opalka, Petr $u Department of Pneumology, Bulovka University Hospital, Prague, Czech Republic $u 3 Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Krakorova, Gabriela $u Department of Pneumology, Bulovka University Hospital, Prague, Czech Republic $u 3 Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Rozsivalova, Denisa $u Department of Respiratory Medicine, University Hospital Olomouc, Olomouc, Czech Republic $u Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
700    1_
$a Kultan, Juraj $u Department of Respiratory Medicine, University Hospital Olomouc, Olomouc, Czech Republic $u Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
700    1_
$a Mullerova, Andrea $u Department of Respiratory Medicine, University Hospital Olomouc, Olomouc, Czech Republic $u Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
700    1_
$a Zarnayova, Lydia $u Department of Respiratory Medicine, University Hospital Olomouc, Olomouc, Czech Republic $u Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
700    1_
$a Smickova, Petra $u Department of Respiratory Medicine, University Hospital Olomouc, Olomouc, Czech Republic $u Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
700    1_
$a Vasakova, Martina $u Department of Respiratory Medicine, Thomayer Hospital, Prague, Czech Republic $u 1 Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Gyorfy, Zsuzsanna $u Department of Respiratory Medicine, Thomayer Hospital, Prague, Czech Republic $u 1 Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Jirousek, Michal $u Pulmonary Department, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic $u Charles University, Faculty of Medicine, Hradec Kralove, Czech Republic
700    1_
$a Krejci, Daniel $u Department of Pneumology, Bulovka University Hospital, Prague, Czech Republic $u 3 Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Krejci, Jana $u Department of Pneumology, Bulovka University Hospital, Prague, Czech Republic $u 3 Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Zuna, Petr $u Department of Pneumology, Bulovka University Hospital, Prague, Czech Republic $u 3 Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Svaton, Martin $u Department of Pneumology, University Hospital Pilsen, Pilsen, Czech Republic $u Faculty of Μedicine in Pilsen, Charles University, Pilsen, Czech Republic
700    1_
$a Hrda, Kristyna $u Department of Pneumology, University Hospital Pilsen, Pilsen, Czech Republic $u Faculty of Μedicine in Pilsen, Charles University, Pilsen, Czech Republic
700    1_
$a Duba, Jaroslav $u OAKS Consulting, Prague, Czech Republic
700    1_
$a Alahakoon, Jana $u OAKS Consulting, Prague, Czech Republic
700    1_
$a Svoboda, Michal $u Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic
700    1_
$a Silar, Jiri $u Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic
773    0_
$w MED00000478 $t Anticancer research $x 1791-7530 $g Roč. 41, č. 11 (2021), s. 5549-5556
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34732425 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127150511 $b ABA008
999    __
$a ok $b bmc $g 1750892 $s 1154417
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 41 $c 11 $d 5549-5556 $e - $i 1791-7530 $m Anticancer research $n Anticancer Res $x MED00000478
LZP    __
$a Pubmed-20220113

Find record

Citation metrics

Archiving options